HuagongsheHuagongshe Chemistry Print Report · For research reference only
5-Chloropyridine-3-boronic acid → (2RS,4R)-6-(5-Chloropyridin-3-yl)-6',6'-difluoro-2-phenyl-6',7'-dihydro-2'H-spiro[chroman-4,5'-[1,4]oxazepin]-3'-amine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 5-Chloropyridine-3-boronic acid | HCID 20111877 | — |
| Reactant | (2RS,4R)-6-bromo-6',6'-difluoro-2-phenyl-6',7'-dihydro-2'H-spiro[chroman-4,5'-[1,4]oxazepin]-3'-amine | HCID 71059735 | — |
| Product | (2RS,4R)-6-(5-Chloropyridin-3-yl)-6',6'-difluoro-2-phenyl-6',7'-dihydro-2'H-spiro[chroman-4,5'-[1,4]oxazepin]-3'-amine | HCID 71059566 | 7% |
Reaction Steps
The cross coupling reaction of (2RS,4R)-6-bromo-6′,6′-difluoro-2-phenyl-6′,7′-dihydro-2′H-spiro[chroman-4,5′-[1,4]oxazepin]-3′-amine (intermediate C3.4) with 5-chloropyridin-3-ylboronic acid yielded the title compound (7% yield) as a white solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09079919B2 |
| Source dataset | uspto-grants-2015_07 |
| ORD ID | ord-bd221f27e81244a79d412bb92564caa2 |
| Source note | uspto-grants-2015_07 |